The University of Chicago Header Logo

Connection

Mark Kozloff to Trastuzumab

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Trastuzumab.
Mark Kozloff
Connection Strength
0.029
Trastuzumab
  1. Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study. BMC Cancer. 2014 Mar 07; 14:166.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.